Market Tracker

09/01 6:58am ET

Alkermes Plc (NASDAQ:ALKS)

44.73
Data as of Aug 29
 +0.25 / +0.56%
Today’s Change
29.36
Today|||52-Week Range
54.25
+10.01%
Year-to-Date

Today’s Trading

Previous close44.48
Today’s open44.74
Day’s range44.37 - 45.07
Volume374,852
Average volume (3 months)725,224
Market cap$6.5B
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-79.67%
Earnings growth (next 5 years)+20.24%
Revenue growth (last year)+47.59%
P/E ratio372.8
Price/Sales5.42
Price/Book6.28

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...+0.26+0.21%
ICPTIntercept Pharmaceut...+0.62+0.21%
TAROTaro Pharmaceutical ...+0.43+0.27%
MDVNMedivation Inc+1.78+1.99%
Data as of 4:02pm ET, 08/29/2014

Financials

Last reporting dateSeptember 1, 2014
EPS forecast (this quarter)$0.03
Annual revenue (last year)$575.5M
Annual profit (last year)$25.0M
Net profit margin4.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts